(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GILEAD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

GILEAD

ST13

US500000086850196

Class

5

Filing

86850196

Registration

5030567

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

08/02/2026

Trademark type

Combined

Nice classes

5

Filing date

12/15/2015

Registration date

08/30/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/02/2026

Last transaction

08/02/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

08/05/2004

First use in commerce

08/05/2004

Drawing code

3

Owner type

03

Owner location

Foster City, CA, US

Examiner

GARTNER, JOHN M

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the placement of the word "GILEAD" in blue, debossed on the front of a three-dimensional configuration of an oblong tablet, also in blue. The broken lines depicting the tablet indicate placement of the mark on the goods and the tablet shape depicted in broken lines, alone, is not part of the mark.

Holders and representatives

Holders

Gilead Sciences, Inc.

Representatives

Jack Wessel Gilead Sciences, Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for the treatment of HIV infection; pharmaceutical preparationspre-exposure prophylaxis (PrEP) preparations for prevention and risk mitigation of contracting HIV

Publications

History of USPTO decisions and trademark events.

29 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/02/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/02/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/02/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/02/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

06/02/2026

NOSU

NOTICE OF SUIT

05/05/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/30/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/16/2021

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/16/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/15/2021

E815

TEAS SECTION 8 & 15 RECEIVED

09/14/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/30/2021

NOSU

NOTICE OF SUIT

03/08/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/30/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/14/2016

PUBO

PUBLISHED FOR OPPOSITION

06/14/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/25/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/10/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/09/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/09/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/09/2016

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

03/11/2016

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

03/11/2016

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

03/11/2016

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

03/11/2016

DOCK

ASSIGNED TO EXAMINER

03/06/2016

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/22/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/21/2015

NWAP

NEW APPLICATION ENTERED

12/18/2015

Continuous trademark protection

Get notified about every new filing that threatens GILEAD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.